Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00026858 · ClinicalTrials.gov registry record · Phase 2

Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts

A Phase 2 study, sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 2
Development phase
100
Enrollment target

NCT00026858: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).

NCT00026858 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00026858, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 2
Development phase
100 participants
Enrollment target

Study Summary

Most bone marrow transplantations for malignant and non-malignant disease include whole body irradiation. Techniques for administering that treatment, including patient positioning, lung and soft tissue compensation, dose rate, total dose and fractionation differ between institutions. These differences are optimized at each institution to limit toxicity and maximize therapeutic outcome. Technically complex procedures such as total body radiation are subject to equipment failures. Such failures mid-treatment could be catastrophic to the patient, since therapy must be timely and compatible therapy may not be available elsewhere in the community. The purpose of this protocol is to provide backup between George Washington University Medical Center and the Radiation Oncology Branch of the NCI to allow for orderly, safe, and compatible therapies in the event of equipment failure; or replacement of a linear accelerator or any other malfunctioning equipment necessary to deliver TBI; or any emergent situation.

Interventions

  • BEHAVIORAL collaboration

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 1994-10
Est. Completion 2002-11
Phase Phase 2

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00026858

The ClinicalTrials.gov registry entry for NCT00026858 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which collaboration is the first listed.

NCT00026858 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00026858 about?

NCT00026858 is a clinical study titled "Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts". Most bone marrow transplantations for malignant and non-malignant disease include whole body irradiation. Techniques for administering that treatment, including patient positioning, lung and soft tissue compensation, dose rate, total dose and fractionation differ between institutions. These differen...

What is the current status of trial NCT00026858?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 1994-10. Estimated completion is 2002-11.

What interventions are being tested in trial NCT00026858?

The interventions under investigation include: collaboration (BEHAVIORAL).

Who is sponsoring clinical trial NCT00026858?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.